New Cancer Immunotherapy Drugs Linked to Arthritis in Some Patients
June 23, 2016
June 23, 2016
BALTIMORE, June 23 -- Johns Hopkins Medicine issued the following news release:
Case reports on 13 cancer patients suggest that a small number of cancer patients taking the immunotherapy drugs ipilimumab and nivolumab may be at some higher-than-normal risk of developing autoimmune joint and tissue diseases, including inflammatory arthritis, according to a preliminary study by Johns Hopkins Medicine researchers.
"I don't think anyone is particularly surprised th . . .
Case reports on 13 cancer patients suggest that a small number of cancer patients taking the immunotherapy drugs ipilimumab and nivolumab may be at some higher-than-normal risk of developing autoimmune joint and tissue diseases, including inflammatory arthritis, according to a preliminary study by Johns Hopkins Medicine researchers.
"I don't think anyone is particularly surprised th . . .